Back to search
FDAFDA · Food and drugs·Recall number Z-0837-2024

Terragene Bionova PCD (PCD222-C)

Published February 7, 2024 · Recall initiated: December 7, 2023

Summary

FDA records medical device Class II recall Z-0837-2024, published February 7, 2024 and initiated December 7, 2023. Recalling firm: TERRAGENE S.A.; Status: Ongoing; Reported quantity: 80 stripes; Lot: Product Number: Terragene Bionova PCD (PCD222-C) UDI-DI code: 07798164676027 Serial Numbers: F20002 F20021 F20046. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Due to a discrepancy between the FDA-Cleared Indications for Use (IFU) and the actual IFU distributed with the products.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
TERRAGENE S.A.
Distributor
U.S. Nationwide distribution in the states of GA, IN, MI, MT, NY, PA, TX and VA.
Lot
Product Number: Terragene Bionova PCD (PCD222-C) UDI-DI code: 07798164676027 Serial Numbers: F20002 F20021 F20046
Risk classification
Class II
Area (FDA)
device
Country
Argentina

Related recalls

Questions about this recall

Was Terragene Bionova PCD (PCD222-C) recalled?

Yes. FDA published recall Z-0837-2024 on February 7, 2024. Reported hazard: Due to a discrepancy between the FDA-Cleared Indications for Use (IFU) and the actual IFU distributed with the products.

What should I do if I have this product?

Voluntary: Firm initiated · Letter